Cytomegalovirus Retinitis Completed Phase 1 Trials for Ganciclovir (DB01004)

Also known as: CMV retinitis / Cytomegaloviral retinitis (disorder) / Cytomegalovirus chorioretinitis / Chorioretinitis caused by Cytomegalovirus (disorder)

IndicationStatusPhase
DBCOND0000283 (Cytomegalovirus Retinitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001062A Study of Ganciclovir in the Treatment of Cytomegalovirus of the EyesTreatment
NCT00000970A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirTreatment
NCT00000668A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral GanciclovirTreatment
NCT00000673A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic TherapyTreatment